Prognostic gene signature present within background liver parenchyma of transplant recipients with hepatocellular carcinoma

被引：0
|
作者：
Brown, A. [1 ]
Zacco, E. [2 ]
Laszik, Z. [3 ]
Stock, P. [4 ]
机构：
[1] Univ Calif San Francisco, Gen Surg, San Francisco, CA USA
[2] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA USA
[3] Univ Calif San Francisco, Clin Pathol, San Francisco, CA USA
[4] Univ Calif San Francisco, Transplant Surg, San Francisco, CA USA
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
eP-065
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [31] A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
    Xie, Hui
    Liu, Shouping
    Zhang, Ziying
    Chen, Peng
    Tao, Yongguang
    JOURNAL OF CANCER, 2020, 11 (19): : 5768 - 5781
  • [32] Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma
    You, Yanjie
    Hu, Shengjuan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (05)
  • [33] A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients
    Agopian, Vatche G.
    Harlander-Locke, Michael
    Zarrinpar, Ali
    Kaldas, Fady M.
    Farmer, Douglas G.
    Yersiz, Hasan
    Finn, Richard S.
    Tong, Myron
    Hiatt, Jonathan R.
    Busuttil, Ronald W.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 220 (04) : 416 - 427
  • [34] PRE-TRANSPLANT FACTORS INFLUENCING RATES OF HEPATOCELLULAR CARCINOMA RECURRENCE IN LIVER TRANSPLANT RECIPIENTS
    Zucker, Kelly
    Gomez, Paul
    Kezirian, Olivia
    Fallon, Michael B.
    Mehta, Shivang
    HEPATOLOGY, 2020, 72 : 648A - 648A
  • [35] Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
    Zucker, Kelly M.
    Gomez, Paul A.
    Kezirian, Olivia
    Mehta, Shivang
    GASTROENTEROLOGY RESEARCH, 2021, 14 (03) : 190 - 193
  • [36] Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma
    Grigg, Sam
    Gow, Paul J.
    Yeomans, Neville
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1330 - 1331
  • [37] Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
    Zhang, Zhi-Hua
    Li, Li Xin
    Li, Ping
    Lv, Shao-Cheng
    Pan, Bing
    He, Qiang
    JOURNAL OF INVESTIGATIVE SURGERY, 2019, 32 (07) : 632 - 641
  • [38] Hepatocellular Carcinoma is the Leading Indication in Liver Transplant Registrants and Recipients in the United States
    Yang, Ju Dona
    Larson, Joseph J.
    Watt, Kymberly
    Allen, Alina M.
    Gores, Gregory J.
    Heimbach, Julie
    Roberts, Lewis R.
    Leise, Michael D.
    HEPATOLOGY, 2016, 64 : 703A - 703A
  • [39] Liver Transplant and Hepatocellular Carcinoma
    Gish, Robert G.
    Clinical Advances in Hematology & Oncology, 2016, 14 (12) : 987 - 989
  • [40] Hepatocellular carcinoma as a independent risk factor for post transplant diabetes in liver recipients
    Bernardes, S. M.
    Goncalez Bovi, T.
    Colitti Lemos, F.
    Minatel Righetto, C.
    Russo Fiore, A.
    Teixeira Lot, L.
    Moura Neto, A.
    de Fatima Ferreira Santana Boin, I.
    DIABETOLOGIA, 2018, 61 : S586 - S587
12345